Phathom Pharmaceuticals, Inc. - PHAT

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$793.6M
QoQ value delta ($000)
+$15.86M (+2.04%)
Implied price effect (QoQ)
-2.35%
Shares
Total shares
73,143,094
QoQ shares delta
+3,146,128 (+4.49%)
Total shares held by funds (by quarter)

Market chart (PHAT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 163 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Frazier Life Sciences Management, L.P. 135,261 12,466,489 2.95%
Medicxi Ventures Management (Jersey) Ltd 80,990 7,464,572 45.65%
BlackRock, Inc. 49,097 4,525,129 0.0%
Invesco Ltd. 43,722 4,029,731 0.0%
Carlyle Group Inc. 37,940 3,496,808 0.38%
MILLENNIUM MANAGEMENT LLC 36,627 3,375,834 0.01%
VANGUARD CAPITAL MANAGEMENT LLC 28,827 2,656,944 0.0%
GW&K Investment Management, LLC 23,510 2,166,838 0.18%
FRANKLIN RESOURCES INC 21,383 1,970,828 0.0%
NEA Management Company, LLC 21,267 1,960,169 1.34%
683 Capital Management, LLC 20,072 1,850,000 0.99%
GOLDMAN SACHS GROUP INC 19,291 1,778,032 0.0%
STATE STREET CORP 17,211 1,586,323 0.0%
Catalys Pacific, LLC 16,208 1,493,854 7.06%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 15,871 1,462,738 0.02%
GEODE CAPITAL MANAGEMENT, LLC 14,277 1,315,687 0.0%
WASATCH ADVISORS LP 14,183 1,307,247 0.09%
Ensign Peak Advisors, Inc 11,413 1,051,913 0.02%
Propel Bio Management, LLC 11,396 1,050,358 5.96%
Point72 Asset Management, L.P. 11,090 1,022,193 0.01%
VANGUARD PORTFOLIO MANAGEMENT LLC 8,643 796,631 0.0%
SummitTX Capital, L.P. 8,566 789,550 0.22%
HSBC HOLDINGS PLC 7,701 709,695 0.0%
CITADEL ADVISORS LLC 7,560 696,801 0.0%
MARSHALL WACE, LLP 7,227 666,090 0.01%